Literature DB >> 10973684

Relative deficiency in IgA production by duodenal explants from German shepherd dogs with small intestinal disease.

A J German1, E J Hall, M J Day.   

Abstract

Matched samples of serum, saliva and tears were collected from four groups of dogs; two of the groups were German shepherd dogs (GSDs) either with (Group 1) or without (Group 4) a variety of small intestinal disorders; the remaining two groups were dogs of other breeds, again with (Group 2) or without (Group 3) small intestinal disease. Capture ELISAs were used to measure IgG, IgM, IgA and albumin concentrations within these samples; intestinal humoral immune status of clinical cases was assessed by quantifying immunoglobulin production from duodenal explant cultures.There were no significant differences in IgG, IgM or IgA concentrations in serum, saliva or tears between the different groups of dog. Moreover, no significant differences were noted between groups for IgG, IgM and IgA salivary and tear secretory indices. IgA production by 24-h explant cultures was significantly lower in GSDs compared with non-GSDs with small intestinal disease (groups 1 and 2, respectively), but the numbers of lamina propria IgA(+) plasma cells in duodenal biopsies were not different between groups. These results suggest that there may be a relative deficiency in local IgA secretion in GSDs with small intestinal enteropathies, which is not reflected in either serum IgA concentrations, or in secretion at unaffected mucosal sites. It remains to be determined whether such a deficiency is a breed-related primary defect, or whether it arises secondary to the pathological processes within the intestinal mucosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973684     DOI: 10.1016/s0165-2427(00)00191-4

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Measurement of immunoglobulin concentrations in the feces of healthy dogs.

Authors:  I R Peters; E L Calvert; E J Hall; M J Day
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

2.  Chronic Enteropathy in Dogs-Epidemiologic Aspects and Clinical Characteristics of Dogs Presenting at Two Swedish Animal Hospitals.

Authors:  Johanna Holmberg; Lena Pelander; Ingrid Ljungvall; Caroline Harlos; Thomas Spillmann; Jens Häggström
Journal:  Animals (Basel)       Date:  2022-06-09       Impact factor: 3.231

3.  Identification of four allelic variants of the dog IGHA gene.

Authors:  Iain R Peters; Chris R Helps; Emma L Calvert; Edward J Hall; Michael J Day
Journal:  Immunogenetics       Date:  2004-07-07       Impact factor: 2.846

4.  Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs.

Authors:  Johannes Junginger; Ulrike Schwittlick; Frederik Lemensieck; Ingo Nolte; Marion Hewicker-Trautwein
Journal:  Vet Res       Date:  2012-03-22       Impact factor: 3.683

5.  Interleukin-13 and interleukin-33 mRNA are underexpressed in the duodenal mucosa of German Shepherd dogs with chronic enteropathy.

Authors:  Aarti Kathrani; Victor Lezcano; Edward J Hall; Albert E Jergens; Yeon-Jung Seo; Jonathan P Mochel; Todd Atherly; Karin Allenspach
Journal:  J Vet Intern Med       Date:  2019-06-06       Impact factor: 3.333

6.  Genomic association and further characterisation of faecal immunoglobulin A deficiency in German Shepherd dogs.

Authors:  Niels Grützner; Romy M Heilmann; Ursula Tress; Iain R Peters; Jan S Suchodolski; Jörg M Steiner
Journal:  Vet Med Sci       Date:  2021-08-14

7.  Immunoglobulins in dogs: correspondence and maturation in 15 litters of German shepherd dogs and their dams.

Authors:  Åsa Vilson; Åke Hedhammar; Arleigh Reynolds; Julie Spears; Ebenezer Satyaraj; Robyn Pelker; Cari Rottman; Bengt Björkstén; Helene Hansson-Hamlin
Journal:  Vet Rec Open       Date:  2016-07-20

Review 8.  Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs.

Authors:  Romy M Heilmann; Jörg M Steiner
Journal:  J Vet Intern Med       Date:  2018-09-17       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.